Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Carole Gourmelon"'
Autor:
Loïg Vaugier, Loïc Ah-Thiane, Maud Aumont, Emmanuel Jouglar, Mario Campone, Camille Colliard, Ludovic Doucet, Jean-Sébastien Frenel, Carole Gourmelon, Marie Robert, Stéphane-André Martin, Tanguy Riem, Vincent Roualdes, Loïc Campion, Augustin Mervoyer
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Glioblastoma (GBM) is frequent in elderly patients, but their frailty provokes debate regarding optimal treatment in general, and the standard 6-week chemoradiation (CRT) in particular, although this is the mainstay for younger patients. All
Externí odkaz:
https://doaj.org/article/9959c315a95c4f11991a2ba7dba0e39b
Autor:
Paule Augereau, Anne Patsouris, Emmanuelle Bourbouloux, Carole Gourmelon, Sophie Abadie Lacourtoisie, Dominique Berton Rigaud, Patrick Soulié, Jean Sebastien Frenel, Mario Campone
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 9 (2017)
Endocrine therapy is the mainstay of treatment of estrogen-receptor-positive (ER+) breast cancer with an overall survival benefit. However, some adaptive mechanisms in the tumor emerge leading to the development of a resistance to this therapy. A bet
Externí odkaz:
https://doaj.org/article/ca4c0958e557434eae385369c0c3ecc5
Autor:
Camille Moreau-Bachelard, Marie Robert, Carole Gourmelon, Emmanuelle Bourbouloux, Anne Patsouris, Jean-Sébastien Frenel, Mario Campone
Publikováno v:
Expert Opinion on Pharmacotherapy. :1-7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d329f29f24c4f10ed9f703f6bce9ecd7
https://doi.org/10.1080/14656566.2023.2214677
https://doi.org/10.1080/14656566.2023.2214677
Autor:
Antoine Seyve, Caroline Dehais, Olivier Chinot, Apolline Djelad, Elisabeth Cohen-Moyal, Charlotte Bronnimann, Carole Gourmelon, Evelyne Emery, Philippe Colin, Mathieu Boone, Elodie Vauléon, Olivier Langlois, Anna-Luisa di Stefano, Romuald Seizeur, François Ghiringhelli, Anne D’Hombres, Loic Feuvret, Jacques Guyotat, Laurent Capelle, Catherine Carpentier, Louis Garnier, Jérôme Honnorat, David Meyronet, Karima Mokhtari, Dominique Figarella-Branger, François Ducray
Publikováno v:
Neuro-Oncology
Neuro-Oncology, 2023, 25 (3), pp.495-507. ⟨10.1093/neuonc/noac194⟩
Neuro-Oncology, 2023, 25 (3), pp.495-507. ⟨10.1093/neuonc/noac194⟩
Background Incidence and characteristics of pseudoprogression in isocitrate dehydrogenase-mutant high-grade gliomas (IDHmt HGG) remain to be specifically described. Methods We analyzed pseudoprogression characteristics and explored the possibility of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0abd8d8fca2683fa6f1bb22183600760
https://u-picardie.hal.science/hal-03753737
https://u-picardie.hal.science/hal-03753737
Autor:
Carole Gourmelon, Dominique Berton Rigaud, Emmanuelle Bourbouloux, Anne Patsouris, Mario Campone, Paule Augereau, Marie Robert, Jean-Sebastien Frenel
Publikováno v:
Expert Review of Anticancer Therapy. 20:85-95
Introduction: Pertuzumab, a humanized monoclonal antibody that binds the human epidermal growth factor receptor 2 (HER2), inhibits the heterodimerization of HER2 with other HER receptors. It has been approved both by the Food and Drug Administration
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c2202d21df26993d0db300220a1e634
https://doi.org/10.1080/14737140.2019.1596805
https://doi.org/10.1080/14737140.2019.1596805
Autor:
Dominique Berton Rigaud, Emmanuelle Bourbouloux, Anne Patsouris, Mario Campone, Paule Augereau, Jean-Sebastien Frenel, Carole Gourmelon, Marie Robert
Publikováno v:
Expert Opinion on Drug Metabolism & Toxicology. 15:85-91
INTRODUCTION The combination of cyclin-dependent kinases 4 and 6 (CDK 4 and 6) inhibitors with endocrine therapy represents a new standard of care for endocrine-receptor positive metastatic breast cancer. Currently, three compounds are approved. Abem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::550dbe91cc90a24b7ef9c17fcf615e96
https://doi.org/10.1080/17425255.2019.1559816
https://doi.org/10.1080/17425255.2019.1559816
Autor:
Mathieu Artifoni, Mélanie Saint-Jean, Emmanuelle Bompas, Audrey Rollot, Judith Raimbourg, Agathe Masseau, Carole Gourmelon, Lucie Peuvrel
Publikováno v:
Annales de Dermatologie et de Vénéréologie - FMC. 1:A321-A322
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::058335c8c1f5fc14bea1ee108cf02975
https://doi.org/10.1016/j.fander.2021.09.371
https://doi.org/10.1016/j.fander.2021.09.371
Autor:
Ludovic Doucet, Axel Cailleteau, Loig Vaugier, Carole Gourmelon, Mathilde Bureau, Celine Salaud, Vincent Roualdes, Edouard Samarut, Maud Aumont, Morgan Zenatri, Delphine Loussouarn, Veronique Quillien, Francois Bocquet, Lea Payen-Gay, Younes Mahi, Alexandre Prieur, Marie Robert, Jean-Sebastien Frenel
Publikováno v:
Journal of Clinical Oncology. 40:2049-2049
2049 Background: hPG80 (circulating progastrin) is a protein secreted by many cancer types, playing a role in tumorigenesis by regulating cancer stem cells, angiogenesis, proliferation/differentiation and decreasing apoptosis. hPG80 is detectable in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c7ae7c16d00a225fbb6bdd355d70b1df
https://doi.org/10.1200/jco.2022.40.16_suppl.2049
https://doi.org/10.1200/jco.2022.40.16_suppl.2049
Autor:
Craig Gedye, David Lorente, Isabelle Dussault, Michael Weller, Morris D. Groves, Hui K Gan, Laureen S. Ojalvo, David A. Reardon, Andrew M. Scott, Kathryn Kolibaba, David Vicente, Chee Khoon Lee, Macarena I. de la Fuente, Mustafa Khasraw, Carole Gourmelon, Christoph Helwig
Publikováno v:
Neuro-oncology Advances
Background For patients with recurrent glioblastoma (rGBM), there are few options following treatment failure with radiotherapy plus temozolomide. Bintrafusp alfa is a first-in-class bifunctional fusion protein composed of the extracellular domain of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b544280046812fdc11a274ddadcf88e
https://pubmed.ncbi.nlm.nih.gov/34056607
https://pubmed.ncbi.nlm.nih.gov/34056607
Autor:
Loïc Campion, Camille Colliard, Vincent Roualdes, Mario Campone, Emmanuel Jouglar, Marie E. Robert, Ludovic Doucet, Carole Gourmelon, Jean-Sebastien Frenel, Tanguy Riem, A. Mervoyer, Loig Vaugier, Maud Aumont, Loïc Ah-Thiane, Stéphane-André Martin
IntroductionGlioblastoma (GBM) is frequent in elderly patients, but their frailty provokes debate regarding optimal treatment in general, and the standard 6-week chemoradiation in particular, although this is the mainstay for younger patients. Method
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ec717751edb31c734b03335b3a1aa682
https://doi.org/10.21203/rs.3.rs-493204/v1
https://doi.org/10.21203/rs.3.rs-493204/v1